| Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast Cancer (NCT06098599) | Luye Pharma Group Ltd. | 2022-05-17 |
| Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF) (NCT05328752) | Novartis Pharmaceuticals | 2022-05-17 |
| A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated (NCT05327946) | Boehringer Ingelheim | 2022-05-17 |
| Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas (NCT05833984) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2022-05-17 |
| Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults (NCT05210413) | University Hospital, Bordeaux | 2022-05-17 |
| A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects (NCT05362695) | Ironwood Pharmaceuticals, Inc. | 2022-05-17 |
| Activated PRP for Treatment of Androgenetic Alopecia (NCT05348343) | Santiste Medical Inc. | 2022-05-17 |
| Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers (NCT04777721) | University of Oxford | 2022-05-17 |
| YL-13027 in Patients With Advanced Solid Tumors (NCT05228600) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2022-05-17 |
| A Study of Two Different Formulations of LY3502970 in Healthy Participants (NCT05341089) | Eli Lilly and Company | 2022-05-17 |
| Effects of a Single Dose of Amisulpride on Functional Brain Changes (NCT05347199) | Simone Grimm | 2022-05-17 |
| Bioequivalence Study of Test and Reference 400 mg Ibuprofen Coated Tablets in Healthy Volunteers (NCT05663398) | Darnitsa Pharmaceutical Company | 2022-05-17 |
| A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. (NCT05322577) | Amgen | 2022-05-17 |
| Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster (NCT05897190) | Argorna Pharmaceuticals Co., LTD | 2022-05-16 |
| A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants (NCT05362045) | Bristol-Myers Squibb | 2022-05-16 |
| A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis (NCT05382819) | Fresh Tracks Therapeutics, Inc. | 2022-05-16 |
| Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting (NCT05282706) | The University of Texas Health Science Center at San Antonio | 2022-05-16 |
| A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors (NCT05387265) | CytomX Therapeutics | 2022-05-16 |
| JAK Inhibition in Food Allergy (NCT05069831) | Icahn School of Medicine at Mount Sinai | 2022-05-16 |
| A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality (NCT05839964) | Canopy Growth Corporation | 2022-05-16 |
| Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? a Pilot Study (NCT05184478) | Murdoch Childrens Research Institute | 2022-05-16 |
| A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers (NCT05471648) | EirGenix, Inc. | 2022-05-16 |
| GVM±R in Patients With Relapsed or Refractory Aggressive NHL (NCT05299164) | Institute of Hematology & Blood Diseases Hospital, China | 2022-05-15 |
| Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines (NCT05155579) | University of Oxford | 2022-05-14 |
| A Study of LP-168 in Healthy Volunteers (NCT05432713) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2022-05-14 |
| A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old (NCT05375838) | ModernaTX, Inc. | 2022-05-13 |
| A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors (NCT05639153) | Zhejiang Doer Biologics Co., Ltd. | 2022-05-13 |
| Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma (NCT05199311) | Hackensack Meridian Health | 2022-05-13 |
| A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010) (NCT06626464) | Merck Sharp & Dohme LLC | 2022-05-13 |
| A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions (NCT05236738) | Bristol-Myers Squibb | 2022-05-13 |
| Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure (NCT05335473) | Henan Cancer Hospital | 2022-05-13 |
| Clinical Trial to Evaluate Pharmacokinetic Characteristics of MIT-001 After SC Administration in Healthy Subjects (NCT05389696) | MitoImmune Therapeutics | 2022-05-13 |
| Oxytocin for Hypermobile Ehlers-Danlos Syndrome (NCT05405257) | Baylor College of Medicine | 2022-05-13 |
| A Healthy Volunteer Study to Compare Fezagepras (PBI-4050) With Sodium Phenylbutyrate (NCT05349435) | Liminal BioSciences Ltd. | 2022-05-13 |
| Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer (NCT05177042) | Arvinas Androgen Receptor, Inc. | 2022-05-13 |
| Six-month Performance of Meniscal Wall Infiltration Under Ultrasound to Treat Stable Degenerative Meniscal Injuries. (NCT05235854) | Centre Hospitalier Universitaire de Nīmes | 2022-05-12 |
| Activity Tracking Study in Healthy Volunteers (MK-0000-419) (NCT06833879) | Merck Sharp & Dohme LLC | 2022-05-12 |
| The Relative Bioavailability of INS068 Injection With Two Different Formulations in Healthy Subjects (NCT05336071) | Jiangsu HengRui Medicine Co., Ltd. | 2022-05-12 |
| Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant (NCT04742634) | Washington University School of Medicine | 2022-05-12 |
| To Evaluate SSD8432/ Ritonavir in Adults With COVID-19 (NCT05369676) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2022-05-12 |
| Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy Participants (NCT05431634) | Alumis Inc | 2022-05-12 |
| Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer (NCT04754321) | Ohio State University Comprehensive Cancer Center | 2022-05-12 |
| Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (NCT05107765) | The University of Texas Health Science Center, Houston | 2022-05-12 |
| A Trial Investigating the Dose Linearity and Safety of BC Combo THDB0207 in Subjects With Type 2 Diabetes (NCT05373212) | Adocia | 2022-05-12 |
| Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia (NCT05357482) | National Heart, Lung, and Blood Institute (NHLBI) | 2022-05-12 |
| CLN-418 Study on Subjects With Advanced Solid Tumors (NCT05306444) | Harbour BioMed US, Inc. | 2022-05-12 |
| A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes (NCT05373199) | Adocia | 2022-05-12 |
| A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors (NCT05318833) | Jiangsu HengRui Medicine Co., Ltd. | 2022-05-12 |
| A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants (NCT05284890) | Bristol-Myers Squibb | 2022-05-12 |
| A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and Lantus® in Healthy Chinese Volunteers (NCT05373186) | Adocia | 2022-05-12 |
| Targeting Stress-Induced Alcohol Relapse Risk With Doxazosin XL (NCT03398252) | The University of Texas Health Science Center, Houston | 2022-05-12 |
| A Clinical Trial Investigating Iloprost as Medication to Improve Bone Healing in Patients With Proximal Humeral Fracture (NCT04543682) | Charite University, Berlin, Germany | 2022-05-12 |
| A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity (NCT05369390) | Novo Nordisk A/S | 2022-05-11 |
| Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition (NCT05336279) | Jiangsu HengRui Medicine Co., Ltd. | 2022-05-11 |
| Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts (NCT05739786) | Combined Military Hospital Abbottabad | 2022-05-11 |
| To Evaluate the Safety, Tolerability and Efficacy in Male and Female with AGA Treated with HMI-115 Over a 24-week Treatment Period (NCT05324293) | Hope Medicine (Nanjing) Co., Ltd | 2022-05-11 |
| Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact (NCT05376527) | "Oncostar" LLC | 2022-05-11 |
| A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020 (NCT05385705) | Vall d'Hebron Institute of Oncology | 2022-05-11 |
| KF2019#1-trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering Drug (NCT05373277) | Helsinki University Central Hospital | 2022-05-11 |
| Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers (NCT05195723) | Moleculin Biotech, Inc. | 2022-05-11 |
| Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users (NCT04003805) | Masonic Cancer Center, University of Minnesota | 2022-05-11 |
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors (NCT05311618) | NGM Biopharmaceuticals, Inc | 2022-05-11 |
| Feasibility Study of Personalized Trials to Improve Sleep Quality (NCT05349188) | Northwell Health | 2022-05-11 |
| A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors (NCT05307705) | Eli Lilly and Company | 2022-05-11 |
| Study of TAVO101 in Healthy Volunteers (NCT05298046) | Tavotek Biotherapeutics | 2022-05-11 |
| NAUTILUS: OKI-179 Plus Binimetinib in Patients with Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NRAS-mutated Melanoma (Phase 2) (NCT05340621) | OnKure, Inc. | 2022-05-11 |
| Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus (NCT05247203) | RemeGen Co., Ltd. | 2022-05-11 |
| A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions (NCT05397834) | Respirent Pharmaceuticals Co Ltd. | 2022-05-11 |
| A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. (NCT05109728) | Novartis Pharmaceuticals | 2022-05-10 |
| Effects of Menthol in E-cigarettes on Smoking Behaviors (NCT04521647) | Yale University | 2022-05-10 |
| Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria. (NCT05373355) | Hangzhou Highlightll Pharmaceutical Co., Ltd | 2022-05-10 |
| [18F]Fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian Cancer (NCT05215496) | Lioe-Fee de Geus-Oei, MD PhD | 2022-05-10 |
| Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors (NCT05188664) | LaNova Australia Pty Limited | 2022-05-10 |
| Submandibular Gland Stem Cell Transplantation (NCT04593589) | University Medical Center Groningen | 2022-05-10 |
| An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma (NCT05315713) | Hoffmann-La Roche | 2022-05-10 |
| To Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal Function (NCT05404542) | Cerevel Therapeutics, LLC | 2022-05-10 |
| Study to Evaluate the Safety of Colchicine (NCT05335148) | Rutgers, The State University of New Jersey | 2022-05-10 |
| A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833 (NCT05364255) | AstraZeneca | 2022-05-10 |
| A Study of PM1015 in Patients With Advanced Solid Tumors (NCT05950815) | Biotheus Inc. | 2022-05-10 |
| Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease (NCT07400224) | Peking Union Medical College Hospital | 2022-05-10 |
| A Study of LY3541105 in Healthy and Overweight Participants (NCT05380323) | Eli Lilly and Company | 2022-05-10 |
| Safety of Co-Administered CHI-554 and Alcohol (NCT05317507) | Auburn University | 2022-05-09 |
| mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation (NCT04525222) | Fred Hutchinson Cancer Center | 2022-05-09 |
| Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule (NCT05361369) | Exeltis Turkey | 2022-05-09 |
| A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers (NCT05372380) | Boryung Pharmaceutical Co., Ltd | 2022-05-09 |
| Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers. (NCT05358106) | Memo Therapeutics AG | 2022-05-09 |
| Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes (NCT05351879) | Linkoeping University | 2022-05-09 |
| Bioavailability Study of Midazolam Administered as a Solution by Conventional Syringe or ZENEO® (NCT05026567) | Crossject | 2022-05-09 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease (NCT05343364) | Phathom Pharmaceuticals, Inc. | 2022-05-09 |
| A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM) (NCT05327595) | Eli Lilly and Company | 2022-05-09 |
| Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. (NCT04771572) | Newave Pharmaceutical Inc | 2022-05-08 |
| CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS (NCT05306457) | Cedars-Sinai Medical Center | 2022-05-08 |
| A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects (NCT05452785) | Journey Medical Corporation | 2022-05-07 |
| Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects (NCT05449535) | Jemincare | 2022-05-07 |
| Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader (NCT05294731) | BeiGene | 2022-05-06 |
| A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants (NCT05344989) | APRINOIA Therapeutics, LLC | 2022-05-06 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19 (NCT05216601) | Medigen Vaccine Biologics Corp. | 2022-05-06 |
| To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects (NCT05363839) | Syneos Health | 2022-05-06 |
| Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma (NCT05141513) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-05-06 |
| Optimal Selenium for Bowel Polyps (OSCAR) (NCT04952129) | University of Auckland, New Zealand | 2022-05-06 |